Review of Leaders’ Actions Affecting Clinical Services at the Syracuse VA Medical Center in New York
Report Information
Summary
The VA Office of Inspector General (OIG) conducted a healthcare inspection at the Syracuse VA Medical Center (facility) to assess allegations of reduced clinical services, poor leadership communication, and staff resignations. The OIG also identified concerns about patient transfer delays and oversight of infrastructure requirements.
The OIG substantiated that clinical services were reduced. The former Facility Director closed the neurosurgery program without submitting a required clinical restructuring request, bypassing national oversight. Facility leaders allowed contracts for infectious disease and endocrinology services to lapse and did not implement contingency plans upon the lapses. The OIG also substantiated eight physicians resigned due to clinical service reductions and deficient communication. Further, coverage requirements of the facility’s complexity designation were not met, which reduced the availability of clinical services. Although the OIG did not identify any adverse patient outcomes, the OIG is concerned about the potential risk.
Facility leaders did not have a process to monitor patient transfer timeliness; therefore, the OIG was unable to determine if delays occurred. Veterans Integrated Service Network and facility leaders also did not provide compulsory oversight of facility infrastructure requirements, increasing risks to patient care.
In response to the OIG’s recommendations, the Acting Under Secretary for Health outlined plans for communicating expectations for infrastructure deficiency waivers. The Interim Veterans Integrated Service Network Director committed to evaluating circumstances that led to facility leaders not following clinical restructuring requirements as well as ensuring accurate infrastructure reviews. The Interim Facility Director also reported plans to verify accurate infrastructure reviews, enhance communication strategies, and examine contracting and patient transfer processes.
The New York/New Jersey VA Healthcare Network Director evaluates the circumstances that led to Network and Syracuse VA Medical Center leaders not following clinical restructuring requirements according to VHA Directive 1043.
The Syracuse VA Medical Center Director evaluates the implementation of high reliability organization principles when communicating changes to clinical operations that include stakeholders, service and section leaders, and staff input.
The Syracuse VA Medical Center Director evaluates facility contract processes and takes action to ensure leaders maintain adequate oversight of contracting milestones.
The Syracuse VA Medical Center Director evaluates the communication of established contingency plans and ensures alignment with high reliability organization principles.
The Syracuse VA Medical Center Director ensures the monitoring and evaluation of patient transfers according to Veterans Health Administration Directive 1094(1) and takes action as warranted.
The Syracuse VA Medical Center Director ensures annual procedural complexity designation infrastructure reviews are completed accurately and ensures administrative actions are performed as required.
The New York/New Jersey VA Healthcare Network Director evaluates fiscal year 2026 procedural complexity designation infrastructure reviews for all Veterans Integrated Service New York/New Jersey VA Health Care Network facilities and takes action to ensure reviews are accurate and deficiencies are addressed as required.
The Under Secretary for Health ensures a timeliness expectation for infrastructure waiver submissions pursuant to Veterans Health Administration Directive 1220(1).